Molecular pathways reflecting poor intrauterine growth are found in Wharton's jelly-derived mesenchymal stem cells

Human Reproduction

Volumn 29, Issue 10, 2014, Pages 2287-2301

  Sukarieh, Rami ^a   Joseph, Roy ^a   Leow, Shi Chi ^a   Li, Ying ^b   Löffler, Mona ^a   Aris, Izzuddin M ^c   Tan, Jun Hao ^a   Teh, Ai Ling ^a   Chen, Li ^a   Holbrook, Joanna D ^a   Ng, Kailyn ^c   Lee, Yung Seng ^a,c   Chong, Yap Seng ^a,c   Summers, Scott A ^b   Gluckman, Peter D ^a,d   Stünkel, Walter ^a  

^a AGENCY FOR SCIENCE   (Singapore)

^b DUKE NUS MEDICAL SCHOOL   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Gene expression; Insulin; Stem cells

Indexed keywords

CYCLOOXYGENASE 2; EARLY GROWTH RESPONSE FACTOR 1; GLUCOSE; INSULIN; EGR1 PROTEIN, HUMAN; PTGS2 PROTEIN, HUMAN;

ARTICLE; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE FUNCTION; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; IN VITRO STUDY; INSULIN SENSITIVITY; MESENCHYMAL STEM CELL; MICROARRAY ANALYSIS; MOLECULAR DYNAMICS; OXIDATIVE STRESS; PRENATAL DEVELOPMENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SMALL FOR DATE INFANT; UMBILICAL CORD; WHARTON JELLY; CYTOLOGY; FETUS DEVELOPMENT; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; NEWBORN;

CELL PROLIFERATION; CYCLOOXYGENASE 2; EARLY GROWTH RESPONSE PROTEIN 1; FETAL DEVELOPMENT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE REGULATORY NETWORKS; GLUCOSE; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; MESENCHYMAL STROMAL CELLS; OXIDATIVE STRESS; UMBILICAL CORD; WHARTON JELLY;

EID: 84922700436     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/deu209     Document Type: Article

References (52)

1. Barker DJ. Outcome of low birthweight. Horm Res 1994;42:223-230.
2. Barker DJ. The fetal origins of coronary heart disease. Acta Paediatr Suppl 1997;422:78-82.
3. Barker DJ, Osmond C, Forsén TJ, Kajantie E, Eriksson JG. Trajectories of growth among children who have coronary events as adults. N Engl J Med 2005;353:1802-1809.
4. Baserga M, Kaur R, Hale MA, Bares A, Yu X, Callaway CW, McKnight RA, Lane RH. Fetal growth restriction alters transcription factor binding and epigenetic mechanisms of renal 11beta-hydroxysteroid dehydrogenase type 2 in a sex-specific manner. Am J Physiol Regul Integr Comp Physiol 2010;299:R334-R342.
5. Bateson P. Preparing offspring for future conditions is adaptive. Trends Endocrinol Metab 2008;19:111.
6. Batsali AK, Kastrinaki MC, Papadaki HA, Pontikoglou C. Mesenchymal stem cells derived from Wharton's Jelly of the umbilical cord: biological properties and emerging clinical applications. Curr Stem Cell Res Ther 2013;8:144-155.
7. Bazaes RA, Salazar TE, Pittaluga E, Peña V, Alegría A, Iñiguez G, Ong KK, Dunger DB, Mericq MV. Glucose and lipid metabolism in small for gestational age infants at 48 hours of age. Pediatrics 2003;111(4 Pt 1):804-809.
8. Berends LM, Fernandez-Twinn DS, Martin-Gronert MS, Cripps RL, Ozanne SE. Catch-up growth following intra-uterine growth-restriction programmes an insulin-resistant phenotype in adipose tissue. Int J Obes (Lond) 2013;37:1051-1057.
9. Bongso A, Fong CY. The therapeutic potential, challenges and future clinical directions of stem cells from the Wharton's jelly of the human umbilical cord. Stem Cell Rev 2013;9:226-240.
10. Cao Z, Liu LZ, Dixon DA, Zheng JZ, Chandran B, Jiang BH. Insulin-like growth factor-I induces cyclooxygenase-2 expression via PI3K, MAPK and PKC signaling pathways in human ovarian cancer cells. Cell Signal 2007;19:1542-1553.
11. Faienza MF, Brunetti G, Ventura A, D'Aniello M, Pepe T, Giordano P, Monteduro M, Cavallo L. Nonalcoholic Fatty liver disease in prepubertal children born small for gestational age: influence of rapid weight catch-up growth. Horm Res Paediatr 2013;79:103-109.
12. Fain JN, Ballou LR, BahouthSW. Obesity is induced in mice heterozygous for cyclooxygenase-2. Prostaglandins Other Lipid Mediat 2001;65:199-209.
13. Fong CY, Subramanian A, Biswas A, Gauthaman K, Srikanth P, Hande MP, Bongso A. Derivation efficiency, cell proliferation, freeze-thaw survival, stem-cell properties and differentiation of human Wharton's jelly stem cells. Reprod Biomed 2010;21:391-401.
14. Fong CY, Chak LL, Biswas A, Tan JH, Gauthaman K, Chan WK, Bongso A. Human Wharton's jelly stem cells have unique transcriptome profiles compared to human embryonic stem cells and other mesenchymal stem cells. Stem Cell Rev 2011;7:1-16.
15. Forsén T, Eriksson J, Tuomilehto J, Reunanen A, Osmond C, Barker D. The fetal and childhood growth of persons who develop type 2 diabetes. Ann Intern Med 2000;133:176-182.
16. Gentz JC, Warrner R, Persson BE. Intravenous glucose tolerance, plasma insulin, free fatty acids and beta-hydroxybutyrate in underweight newborn infants. Acta Paediatr Scand 1969;58:481-490.
17. Godfrey KM, Inskip HM, Hanson MA. The long-term effects of prenatal development on growth and metabolism. Semin Reprod Med 2011; 29:257-265.
18. González-Ortiz M, Martínez-Abundis E, Balcázar-Muñoz BR, Robles- Cervantes JA. Inhibition of cyclooxygenase-1 or -2 on insulin sensitivity in healthy subjects. Horm Metab Res 2001;33:250-253.
19. Gluckman PD, Hanson MA. Maternal constraint of fetal growth and its consequences. Semin Fetal Neonatal Med 2004;9:419-425.
20. Gluckman PD, Hanson MA. The consequences of being born small-an adaptive perspective. Horm Res 2006;65(Suppl 3):5-14.
21. Gluckman PD, Hanson MA, Low FM. The role of developmental plasticity and epigenetics in human health. Birth Defects Res C Embryo Today 2011; 93:12-18.
22. Hadlock FP, Deter RL, Harrist RB, Park SK. Fetal abdominal circumference as a predictor of menstrual age. AJR Am J Roentgenol 1982;139:367-370.
23. Hadlock FP, Harrist RB, Carpenter RJ, Deter RL, Park SK. Sonographic estimation of fetal weight. The value of femur length in addition to head and abdomen measurements. Radiology 1984;150:535-540.
24. Hales CN, Barker DJ. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 1992;35:595-601.
25. Hanson MA, Gluckman PD. Developmental origins of health and disease: moving from biological concepts to interventions and policy. Int J Gynaecol Obstet 2011;115(Suppl 1):3.
26. Hanson M, Godfrey KM, Lillycrop KA, Burdge GC, Gluckman PD. Developmental plasticity and developmental origins of non-communicable disease: theoretical considerations and epigenetic mechanisms. Prog Biophys Mol Biol 2011;106:272-280.
27. Higaki Y, Mikami T, Fujii N, Koyama K, Seino T, Tanaka K, Goodyear LJ. Oxidative stress stimulates skeletal muscle glucose uptake through a phosphatidylinositol 3-kinase-dependent pathway. Am J Physiol Endocrinol Metab 2008;294:E889-E897.
28. Hofman PL, Cutfield WS, Robinson EM, Bergman RN, Menon RK, Sperling MA, Gluckman PD. Insulin resistance in short children with intrauterine growth retardation. J Clin Endocrinol Metab 1997; 82:402-406.
29. Howie GJ, Sloboda DM, Kamal T, Vickers MH. Maternal nutritional history predicts obesity in adult offspring independent of postnatal diet. J Physiol 2009;587(Pt 4):905-915.
30. Hsieh PS, Jin JS, Chiang CF, Chan PC, Chen CH, Shih KC. COX-2-mediated inflammation in fat is crucial for obesity-linked insulin resistance and fatty liver. Obesity (Silver Spring) 2009;17:1150-1157.
31. Keeton AB, Bortoff KD, Bennett WL, Franklin JL, Venable DY, Messina JL. Insulin-regulated expression of Egr-1 and Krox20: dependence on ERK1/2 and interaction with p38 and PI3-kinase pathways. Endocrinology 2003;144:5402-5410.
32. KuzawaCW. Adipose tissue in human infancy and childhood: an evolutionary perspective. Am J Phys Anthropol 1998;(Suppl 27):177-209.
33. Leonard WR, Robertson ML, Snodgrass JJ, Kuzawa CW. Metabolic correlates of hominid brain evolution. Comp Biochem Physiol A Mol Integr Physiol 2003;136:5-15.
34. Liu J, Liu YG, Huang R, Yao C, Li S, YangW, Yang D, Huang RP. Concurrent down-regulation of Egr-1 and gelsolin in the majority of human breast cancer cells. Cancer Genomics Proteomics 2007;4:377-385.
35. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25:402-408.
36. Low FM, Gluckman PD, Hanson MA. Developmental plasticity and epigenetic mechanisms underpinning metabolic and cardiovascular diseases. Epigenomics 2011;3:279-294.
37. Madsen L, Pedersen LM, Lillefosse HH, Fjaere E, Bronstad I, Hao Q, Petersen RK, Hallenborg P, Ma T, De Matteis R et al. UCP1 induction during recruitment of brown adipocytes in white adipose tissue is dependent on cyclooxygenase activity. PLoS One 2010;5:e11391.
38. Mericq V, Ong KK, Bazaes R, Peña V, Avila A, Salazar T, Soto N, Iñiguez G, Dunger DB. Longitudinal changes in insulin sensitivity and secretion from birth to age three years in small- and appropriate-for-gestational-age children. Diabetologia 2005;48:2609-2614.
39. Morrison JL, Duffield JA, Muhlhausler BS, Gentili S, McMillen IC. Fetal growth restriction, catch-up growth and the early origins of insulin resistance and visceral obesity. Pediatr Nephrol 2010;25:669-677.
40. Roseboom TJ, van der Meulen JH, Osmond C, Barker DJ, Ravelli AC, Schroeder-Tanka JM, van Montfrans GA, Michels RP, Bleker OP. Coronary heart disease after prenatal exposure to the Dutch famine, 1944-45. Heart 2000;84:595-598.
41. Sarsour EH, Sarsour EH, Kalen AL, Veenstra TD, Chaudhuri L, Venkataraman S, Reigan P, Buettner GR, Goswami PC. Manganese superoxide dismutase regulates a metabolic switch during the mammalian cell cycle. Cancer Res 2012;72:3807-3816.
42. Shen N, Yu X, Pan FY, Gao X, Xue B, Li CJ. An early response transcription factor, Egr-1, enhances insulin resistance in type 2 diabetes with chronic hyperinsulinism. J Biol Chem 2011;286:14508-14515.
43. Simmons RA. Developmental origins of diabetes: the role of oxidative stress. Best Pract Res Clin Endocrinol Metab 2012;26:701-708.
44. Simmons DL, Botting RM, Hla T. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev 2004; 56:387-437.
45. Singhal A, Fewtrell M, Cole TJ, Lucas A. Lownutrient intake and early growth for later insulin resistance in adolescents born preterm. Lancet 2003; 361:1089-1097.
46. Soh SE, Tint MT, Gluckman PD, Godfrey KM, Rifkin-Graboi A, Chan YH, Stünkel W, Holbrook JD, Kwek K, Chong YS et al. Cohort Profile: Growing Up in Singapore Towards healthy Outcomes (GUSTO) birth cohort study. Int J Epidemiol 2013. doi:10.1093/ije/dyt125.
47. Soto N, Bazaes RA, PeñaV, SalazarT, Avila A, Iñiguez G, OngKK, Dunger DB, Mericq M. Insulin sensitivity and secretion are related to catch-up growth in small-for-gestational-age infants at age 1 year: results from a prospective cohort. J Clin Endocrinol Metab 2003;88:3645-3650.
48. Sung HY, Guan H, Czibula A, King AR, Eder K, Heath E, Suvarna SK, Dower SK, Wilson AG, Francis SE et al. Human tribbles-1 controls proliferation and chemotaxis of smooth muscle cells via MAPK signaling pathways. J Biol Chem 2007;282:18379-18387.
49. Tarry-Adkins JL, Ozanne SE. Mechanisms of early life programming: current knowledge and future directions. Am J Clin Nutr 2011;94:(6 Suppl):1765S-1771S.
50. Wang HS, Hung SC, Peng ST, Huang CC, Wei HM, Guo YJ, Fu YS, Lai MC, Chen CC. Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells 2004;22:1330-1337.
51. Yokoyama T, Nakamura T. Tribbles in disease: signaling pathways important for cellular function and neoplastic transformation. Cancer Sci 2011; 102:1115-1122.
52. Yu X, Shen N, Zhang ML, Pan FY, Wang C, Jia WP, Liu C, Gao Q, Gao X, Xue B et al. Egr-1 decreases adipocyte insulin sensitivity by tilting PI3K/ Akt and MAPK signal balance in mice. EMBO J 2011;30:3754-3765.